+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Phenylbutazone API Market - Global Forecast 2026-2032- Product Image
Phenylbutazone API Market - Global Forecast 2026-2032- Product Image
Sale

Phenylbutazone API Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6159593
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Phenylbutazone API: Executive Overview

Phenylbutazone API is the active pharmaceutical ingredient used to manufacture phenylbutazone medicines, primarily for veterinary applications. Its market environment is shaped by veterinary prescribing practices, animal-health regulation, manufacturing controls, and the availability of compliant pharmaceutical-grade supply. Because phenylbutazone has important safety restrictions, demand is closely linked to approved indications, species-specific use, residue controls, and professional oversight.

Regulatory Control and Supply Assurance Are Reshaping the Landscape

The landscape is being transformed by tighter pharmacovigilance, residue-monitoring requirements, and expectations for documented quality across the active-ingredient supply chain. Manufacturers and buyers increasingly prioritize validated processes, traceability, impurity control, stable documentation, and reliable batch release. Veterinary restrictions-especially those involving food-producing animals-continue to influence formulation choices, prescribing behavior, and regional procurement. These shifts favor disciplined compliance and technically consistent production over undifferentiated volume availability.

Artificial Intelligence Strengthens Quality, Planning, and Safety Workflows

Artificial intelligence can improve phenylbutazone API operations by supporting demand sensing, supplier-risk screening, deviation investigation, document review, and trend analysis across quality records. Machine-learning tools may also help identify unusual impurity patterns, optimize analytical workflows, and prioritize pharmacovigilance signals. However, AI does not replace validated laboratory methods, qualified personnel, regulatory judgment, or controlled manufacturing procedures. Its practical value depends on high-quality data, auditability, cybersecurity, and human review within the pharmaceutical quality system.

Regional Insights: Regulation and Veterinary Use Define Local Conditions

North America emphasizes veterinary oversight, controlled labeling, supply reliability, and residue compliance. Latin America presents varied regulatory maturity and procurement conditions, making local registration, distributor qualification, and documentation important. Europe places strong weight on animal-medicinal-product authorization, pharmacovigilance, environmental considerations, and food-chain safeguards. The Middle East is influenced by import procedures, centralized purchasing, and dependence on qualified external supply. Africa shows diverse veterinary infrastructure and regulatory capacity, increasing the importance of adaptable distribution and technical support. Asia-Pacific combines substantial pharmaceutical manufacturing capability with varied national rules, creating opportunities for qualified production while requiring careful country-level compliance management.

Group Insights: Economic and Regulatory Blocs Create Different Operating Priorities

ASEAN markets require attention to differing national registration systems, import rules, and veterinary-use practices despite regional cooperation. BRICS economies combine important manufacturing, agricultural, and animal-health interests but retain distinct regulatory pathways and quality expectations. The European Union operates through a comparatively integrated framework emphasizing authorization, traceability, and safety controls. G7 markets generally apply mature quality, pharmacovigilance, and documentation standards. GCC markets are shaped by import dependence, centralized procurement, and regionally coordinated regulatory activity. NATO members are not governed by a single pharmaceutical framework, but many operate in environments where resilient medical and veterinary supply chains, quality assurance, and strategic sourcing receive elevated attention.

Country Insights: National Rules and Veterinary Practice Remain Decisive

Australia applies stringent veterinary and residue controls, while Brazil combines a large animal-health base with detailed registration and manufacturing requirements. Canada emphasizes licensed veterinary products, quality systems, and food-safety oversight. China has significant pharmaceutical manufacturing capacity and country-specific regulatory controls. France, Germany, Italy, and Spain operate within the European Union framework, with national implementation and veterinary-market practices influencing execution. India offers broad pharmaceutical manufacturing expertise but requires careful attention to domestic and export compliance. Japan and South Korea maintain advanced regulatory and quality environments. Mexico combines North American supply-chain links with its own registration and import procedures. Russia presents distinct regulatory, trade, and supply considerations. The United Kingdom maintains an independent post-EU regulatory framework. The United States places strong emphasis on veterinary authorization, manufacturing quality, labeling, and residue-related safeguards.

Actions for Leaders: Build Compliance-Led Resilience

Industry leaders should qualify multiple compliant sources where legally permissible, strengthen supplier audits, and maintain complete certificates, specifications, and traceability records. They should segment products by approved species and indication, reinforce controls that prevent inappropriate food-animal use, and monitor regulatory changes in every destination market. Investment in validated analytical capability, impurity and stability programs, business-continuity planning, and pharmacovigilance partnerships can reduce operational exposure. AI should be deployed selectively for quality and planning workflows, with documented validation, access controls, and human accountability. Commercial decisions should prioritize sustainable compliance and technical reliability rather than price alone.

Research Methodology: Evidence-Based Market Assessment

This executive summary uses the supplied market definition-phenylbutazone API-and organizes findings across regulatory, manufacturing, veterinary-use, quality, technology, and geographic dimensions. The assessment interprets publicly established industry conditions and general pharmaceutical operating requirements without introducing market estimates, shares, forecasts, or unsupported company-specific claims. Regional, group, and country observations are framed as qualitative insights and should be validated against current legislation, approved-product databases, customs requirements, and local veterinary guidance before operational decisions are made.

Conclusion: Quality, Governance, and Responsible Use Will Shape Competitiveness

The phenylbutazone API environment is defined less by undifferentiated demand than by the ability to meet strict quality, regulatory, and responsible-use expectations. Regional and national differences require tailored compliance strategies, while global supply uncertainty increases the value of qualified sourcing and transparent documentation. Organizations that combine validated manufacturing, strong stewardship, resilient procurement, and carefully governed digital tools will be better positioned to serve legitimate veterinary applications while managing safety and regulatory risk.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Phenylbutazone API Market, by Product Type
7.1. Introduction
7.2. Branded
7.3. Generic
8. Phenylbutazone API Market, by Formulation
8.1. Introduction
8.2. Concentrate
8.3. Powder
8.4. Solution
9. Phenylbutazone API Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Topical
10. Phenylbutazone API Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sale
10.3. Distributor
10.4. Online
11. Phenylbutazone API Market, by Application
11.1. Introduction
11.2. Analgesic
11.3. Anti Inflammatory
11.4. Antipyretic
12. Phenylbutazone API Market, by End User
12.1. Introduction
12.2. Contract Manufacturers
12.3. Pharmaceutical Companies
12.4. Research Institutes
13. Phenylbutazone API Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Phenylbutazone API Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Phenylbutazone API Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. A B Enterprises
17.2. AMGIS Lifescience Ltd.
17.3. Arshine Pharmaceutical Co., Limited
17.4. Aurora Industry Co., Ltd.
17.5. Bakul Pharma
17.6. Beijing Taiyang Pharmaceutical Industry Co., Ltd.
17.7. Century Pharmaceutical Limited
17.8. Krishkan Chemicals
17.9. LGM Pharma
17.10. Manus Aktteva Biopharma LLP
17.11. Nantong Jinghua Pharmaceutical Co., Ltd.
17.12. Reine Lifescience
17.13. Shreeji Pharma International
17.14. Sichuan Xieli Pharmaceutical Co., Ltd.
17.15. Swati Chemicals
17.16. Therawin Formulations
17.17. Verdant Life Sciences Pvt. Ltd.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Phenylbutazone API Market, Years Considered for the Study
FIGURE 2. Global Phenylbutazone API Market, Research Design
FIGURE 3. Global Phenylbutazone API Market, Research Framework
FIGURE 4. Global Phenylbutazone API Market, Data Triangulation
FIGURE 5. Global Phenylbutazone API Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Phenylbutazone API Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Phenylbutazone API Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Phenylbutazone API Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 9. Global Phenylbutazone API Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Phenylbutazone API Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Phenylbutazone API Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Phenylbutazone API Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Phenylbutazone API Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Phenylbutazone API Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Phenylbutazone API Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Phenylbutazone API Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Phenylbutazone API Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Phenylbutazone API Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Phenylbutazone API Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Phenylbutazone API Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Phenylbutazone API Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Phenylbutazone API Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Phenylbutazone API Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Phenylbutazone API Market Segmentation & Coverage
TABLE 2. Global Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 3. Global Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Branded Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Branded Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Branded Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 11. Global Concentrate Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Concentrate Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Concentrate Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 21. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 31. Global Direct Sale Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Direct Sale Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Direct Sale Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Distributor Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Distributor Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Distributor Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 41. Global Analgesic Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Analgesic Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Analgesic Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Anti Inflammatory Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Anti Inflammatory Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Anti Inflammatory Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Antipyretic Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Antipyretic Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Antipyretic Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 51. Global Contract Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Contract Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Contract Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Phenylbutazone API Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Phenylbutazone API Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. North America Phenylbutazone API Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. North America Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 70. North America Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 71. North America Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 72. North America Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 73. North America Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 74. North America Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. Latin America Phenylbutazone API Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Latin America Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 77. Latin America Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 78. Latin America Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 79. Latin America Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. Latin America Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. Latin America Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Europe Phenylbutazone API Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Europe Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 84. Europe Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 85. Europe Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 86. Europe Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 87. Europe Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. Europe Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Middle East Phenylbutazone API Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Middle East Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 91. Middle East Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 92. Middle East Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 93. Middle East Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 94. Middle East Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. Middle East Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Africa Phenylbutazone API Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Africa Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 98. Africa Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 99. Africa Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 100. Africa Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 101. Africa Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. Africa Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. Global Phenylbutazone API Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. ASEAN Phenylbutazone API Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. ASEAN Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 106. ASEAN Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 107. ASEAN Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 108. ASEAN Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 109. ASEAN Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. ASEAN Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. GCC Phenylbutazone API Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. GCC Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. GCC Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 114. GCC Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 115. GCC Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. GCC Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. GCC Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. European Union Phenylbutazone API Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. European Union Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 120. European Union Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 121. European Union Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 122. European Union Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. European Union Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 124. European Union Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. BRICS Phenylbutazone API Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. BRICS Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. BRICS Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 128. BRICS Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 129. BRICS Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 130. BRICS Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. BRICS Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. G7 Phenylbutazone API Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. G7 Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 134. G7 Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 135. G7 Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 136. G7 Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 137. G7 Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. G7 Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. NATO Phenylbutazone API Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. NATO Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. NATO Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 142. NATO Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 143. NATO Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 144. NATO Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. NATO Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. Global Phenylbutazone API Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. United States Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 148. United States Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. United States Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 150. United States Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 151. United States Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. United States Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. United States Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Canada Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 155. Canada Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 156. Canada Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 157. Canada Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 158. Canada Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 159. Canada Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. Canada Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Mexico Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 162. Mexico Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. Mexico Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 164. Mexico Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 165. Mexico Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. Mexico Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. Mexico Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. Brazil Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 169. Brazil Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 170. Brazil Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 171. Brazil Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 172. Brazil Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. Brazil Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Brazil Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. United Kingdom Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 176. United Kingdom Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. United Kingdom Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 178. United Kingdom Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 179. United Kingdom Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. United Kingdom Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. United Kingdom Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Germany Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 183. Germany Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 184. Germany Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 185. Germany Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 186. Germany Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 187. Germany Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. Germany Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. France Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 190. France Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. France Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 192. France Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 193. France Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. France Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. France Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Russia Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 197. Russia Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. Russia Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 199. Russia Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 200. Russia Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 201. Russia Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. Russia Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Italy Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 204. Italy Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. Italy Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 206. Italy Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 207. Italy Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. Italy Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. Italy Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. Spain Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 211. Spain Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. Spain Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 213. Spain Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 214. Spain Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 215. Spain Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. Spain Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. China Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 218. China Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. China Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 220. China Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 221. China Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 222. China Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 223. China Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 224. India Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 225. India Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. India Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 227. India Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 228. India Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 229. India Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. India Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Japan Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 232. Japan Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 233. Japan Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 234. Japan Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 235. Japan Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 236. Japan Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 237. Japan Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. Australia Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 239. Australia Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. Australia Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 241. Australia Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 242. Australia Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 243. Australia Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. Australia Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. South Korea Phenylbutazone API Market Size, 2017-2032 (USD Million)
TABLE 246. South Korea Phenylbutazone API Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 247. South Korea Phenylbutazone API Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 248. South Korea Phenylbutazone API Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 249. South Korea Phenylbutazone API Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 250. South Korea Phenylbutazone API Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. South Korea Phenylbutazone API Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. Global Phenylbutazone API Market Share, by Key Player, 2025
TABLE 253. Global Phenylbutazone API Market, Key Experts

Companies Mentioned

  • A B Enterprises
  • AMGIS Lifescience Ltd.
  • Arshine Pharmaceutical Co., Limited
  • Aurora Industry Co., Ltd.
  • Bakul Pharma
  • Beijing Taiyang Pharmaceutical Industry Co., Ltd.
  • Century Pharmaceutical Limited
  • Krishkan Chemicals
  • LGM Pharma
  • Manus Aktteva Biopharma LLP
  • Nantong Jinghua Pharmaceutical Co., Ltd.
  • Reine Lifescience
  • Shreeji Pharma International
  • Sichuan Xieli Pharmaceutical Co., Ltd.
  • Swati Chemicals
  • Therawin Formulations
  • Verdant Life Sciences Pvt. Ltd.

Related Topics

Related Reports

Phenylbutazone (CAS 50-33-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Phenylbutazone (CAS 50-33-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Phenylbutazone Calcium (CAS 70145-60-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Phenylbutazone Calcium (CAS 70145-60-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Diclazuril Veterinary Drug API Market - Global Forecast 2026-2032 - Product Image

Diclazuril Veterinary Drug API Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Carbinoxamine Maleate API Market - Global Forecast 2026-2032 - Product Image

Carbinoxamine Maleate API Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Veterinary API Market Size, Share & Trends Analysis Report by Animal (Production, Companion), Service (in House, Contract Outsourcing), Synthesis (Chemical Based API, Biological API, HPAPI), Therapeutic Category, and Region with Growth Forecasts, 2026-2033 - Product Image

Veterinary API Market Size, Share & Trends Analysis Report by Animal (Production, Companion), Service (in House, Contract Outsourcing), Synthesis (Chemical Based API, Biological API, HPAPI), Therapeutic Category, and Region with Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.